Practical Guidance for Engaging Patients in Health Research, Treatment Guidelines and Regulatory Processes: Results of An Expert Group Meeting Organized by The World Health Organization (WHO) And the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Maarten de Wit, Amsterdam University Medical Centre
Cyrus Cooper, University of Southampton
Peter Tugwell, University of Ottawa
Nathalie Bere, European Medicines Agency
John Kirwan, University of Bristol
Philip G. Conaghan, University of Leeds
Charlotte Roberts, International Consortium for Health Outcomes Measurement
Isabelle Aujoulat, Institute of Health & Society
Nasser Al-Daghri, King Saud University
Islene Arajujo de Carvalho, World Health Organization
Mary Barker, University of Southampton
Nicola Bedlington, European Patients’ Forum
Maria Luisa Brandi, University of Florence
Olivier Bruyère, University of Liège
Nansa Burlett, WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging
Philippe Halbout, International Osteoporosis Foundation
Mickaël Hiligsmann, Maastricht University
Famida Jiwa, Osteoporosis Canada
John A. Kanis, University of Sheffield
Andrea Laslop, Austrian Agency for Health and Food Safety
Wendy Lawrence, Southampton General Hospital
Daniel Pinto, Marquette University
Concepción Prieto Yerro, Spanish Agency for Drugs and Medical Devices
Véronique Rabenda, University of Liège
René Rizzoli, Geneva University Hospitals
Marieke Scholte-Voshaar, University of Twente
Mila Vlaskovska, Medical University Sofia
Jean-Yves Reginster, King Saud University

Accepted version. Aging Clinical and Experimental Research, Vol. 31, No. 7 (July 2019) : 905-915. DOI. © 2019 Springer. Used with permission.

Shareable link provided by Springer Nature SharedIt content-sharing initiative.

Abstract

There is increasing emphasis on patient-centred research to support the development, approval and reimbursement of health interventions that best meet patients’ needs. However, there is currently little guidance on how meaningful patient engagement may be achieved. An expert working group, representing a wide range of stakeholders and disciplines, was convened by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the World Health Organization (WHO). Through a structured, collaborative process the group generated practical guidance to facilitate optimal patient engagement in clinical development and regulatory decisions. Patient engagement is a relational process. The principles outlined in this report were based on lessons learned through applied experience and on an extensive dialogue among the expert participants. This practice guidance forms a starting point from which tailoring of the approach to suit different chronic diseases may be undertaken.